(Q37037458)

17 August 2017

1 reference

title

Nonalcoholic fatty liver disease and diabetes mellitus (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

17 August 2017

0 references

1 reference

1 reference

Leon A Adams

1

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

32

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

59-69

1 reference

Nonalcoholic fatty liver disease

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Apolipoprotein synthesis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The metabolic abnormalities associated with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic fatty liver disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Chronological development of elevated aminotransferases in a nonalcoholic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Statins and hepatotoxicity: focus on patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07435800701743885

10.1080/07435800701743885

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference